Author:
Li Yiting,Cai Haifeng,Sussman Daniel A.,Donet Jean,Dholaria Kevin,Yang Jiajia,Panara Ami,Croteau Ryan,Barkin Jamie S.
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Reference70 articles.
1. Ananthakrishnan AN. Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol. 2011;8:17–26.
2. Stranges PM, Hutton DW, Collins CD. Cost-effectiveness analysis evaluating fidaxomicin versus oral vancomycin for the treatment of Clostridium difficile infection in the United States. Value Health. 2013;16:297–304.
3. Surawicz CM, Brandt LJ, Binion DG et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013;108:478–498.
4. van Werkhoven CH, van der Tempel J, Jajou R et al. Identification of patients at high risk for Clostridium difficile infection: development and validation of a risk prediction model in hospitalized patients treated with antibiotics. Clin Microbiol Infect Official Public Eur Soc Clin Microbiol Infect Dis. 2015;21:e781-788.
5. Kuntz JL, Johnson ES, Raebel MA et al. Predicting the risk of Clostridium difficile infection following an outpatient visit: development and external validation of a pragmatic, prognostic risk score. Clin Microbiol Infect Official Public Eur Soc Clin Microbiol Infect Dis. 2015;21:256–262.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献